Adaptive Biotechnologies Corporation (ADPT)
7.61
-0.09 (-1.23%)
At close: Apr 08, 2025, 3:59 PM
7.69
1.09%
Pre-market: Apr 09, 2025, 07:01 AM EDT
Adaptive Biotechnologies Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
9
Upside
18.34
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Goldman Sachs | Strong Buy | Upgrades | 8 9 | 18.34% | Mar 21, 2025 | |
| Piper Sandler | Buy | Initiates | 7 11 | 44.64% | Feb 20, 2025 | |
| Scotiabank | Buy | Maintains | 10 12 | 57.79% | Feb 13, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.